Wolff Wiese Magana’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-145
| Closed | -$102 | – | 755 |
|
|
2023
Q4 | $102 | Sell |
145
-6
| -4% | -$4 | ﹤0.01% | 696 |
|
|
2023
Q3 | $105 | Hold |
151
| – | – | ﹤0.01% | 772 |
|
|
2023
Q2 | $364 | Sell |
151
-2
| -1% | -$5 | ﹤0.01% | 723 |
|
|
2023
Q1 | $1.25K | Hold |
153
| – | – | ﹤0.01% | 562 |
|
|
2022
Q4 | $1.82K | Hold |
153
| – | – | ﹤0.01% | 513 |
|
|
2022
Q3 | $2K | Hold |
153
| – | – | ﹤0.01% | 729 |
|
|
2022
Q2 | $5K | Hold |
153
| – | – | ﹤0.01% | 648 |
|
|
2022
Q1 | $6K | Hold |
153
| – | – | ﹤0.01% | 625 |
|
|
2021
Q4 | $6K | Hold |
153
| – | – | ﹤0.01% | 617 |
|
|
2021
Q3 | $10K | Hold |
153
| – | – | 0.01% | 528 |
|
|
2021
Q2 | $12K | Hold |
153
| – | – | 0.01% | 478 |
|
|
2021
Q1 | $10K | Hold |
153
| – | – | 0.01% | 485 |
|
|
2020
Q4 | $5K | Buy |
+153
| New | +$5K | ﹤0.01% | 550 |
|